CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-0851
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab) ; day:16 ; month:11 ; year:2020 ; pages:1-8
Cancer immunology immunotherapy ; (16.11.2020), 1-8

Creator
Fietz, Simon
Zarbl, Romina
Niebel, Dennis
Posch, Christian
Brossart, Peter
Gielen, Gerrit H.
Strieth, Sebastian
Pietsch, Torsten
Kristiansen, Glen
Bootz, Friedrich
Landsberg, Jennifer
Dietrich, Dimo
Contributor
SpringerLink (Online service)

DOI
10.1007/s00262-020-02777-4
URN
urn:nbn:de:101:1-2020122720325215533709
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Fietz, Simon
  • Zarbl, Romina
  • Niebel, Dennis
  • Posch, Christian
  • Brossart, Peter
  • Gielen, Gerrit H.
  • Strieth, Sebastian
  • Pietsch, Torsten
  • Kristiansen, Glen
  • Bootz, Friedrich
  • Landsberg, Jennifer
  • Dietrich, Dimo
  • SpringerLink (Online service)

Other Objects (12)